Literature DB >> 11233243

Obliterative airway disease and graft stenting in pig-to-dog tracheal xenotransplantation.

K Kawahara1, M Hiratsuka, K Mikami, S Makihata, S Yoneda, T Shiraishi, K Okabayashi, T Shirakusa.   

Abstract

OBJECTIVE: Obliterative airway disease occurring in concordant tracheal xenografts in rodent models is histologically similar to obliterative bronchiolitis in human lung allografts. We studied whether obliterative airway disease would occur in a large animal-discordant model.
METHODS: Pig and dog tracheas were cryopreserved for 7 to 14 days, and 18 recipient dogs given splenectomy 7 days before transplantation, then seven tracheal rings were removed and a corresponding five-ring donor tracheal segment was transplanted to the excised site. Grafts were wrapped with pedicled omentum and inmmunosuppression was conducted with tacrolimus or deoxyspergualin. Graft status was observed by bronchoscopy. Dogs were classified into three groups. Group 1 consisted of dog-to-dog allotransplantation animals (control group, n = 5), Group 2 of pig-to-dog xenotransplantation animals (n = 8), and Group 3 of pig-dog xenotransplantation animals who also underwent graft stenting immediately after transplantation (n = 5).
RESULTS: Grafts healed well in 4 of 5 Group 1 dogs. Tracheal stricture began on day 5 post transplantation and the lumen was obstructed by fibrosis by days 8 to 14 in all Group 2 dogs. All Group 3 dogs remained in good respiratory status until death.
CONCLUSION: Obliterative airway disease developed quickly in pig-to-dog discordant tracheal xenografts. Graft stenting is a feasible treatment for managing of tracheal obstruction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233243     DOI: 10.1007/bf02913124

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  20 in total

1.  Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.

Authors:  H Reichenspurner; V Soni; M Nitschke; G J Berry; T R Brazelton; R Shorthouse; X Huang; B A Reitz; R E Morris
Journal:  Transplantation       Date:  1997-08-15       Impact factor: 4.939

2.  T-TUBE TRACHEAL STENT.

Authors:  W W MONTGOMERY
Journal:  Arch Otolaryngol       Date:  1965-09

3.  FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.

Authors:  F Pan; L A Valdivia; M Tsugita; S Celli; K Haeuchi; A J Demetris; G Avci; J J Fung
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

4.  Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs.

Authors:  K Inutsuka; K Kawahara; T Takachi; K Okabayashi; T Shiraishi; T Shirakusa
Journal:  Ann Thorac Surg       Date:  1996-11       Impact factor: 4.330

5.  Clinical evaluation of a new bifurcated dynamic airway stent: a 5-year experience with 135 patients.

Authors:  L Freitag; E Tekolf; G Stamatis; D Greschuchna
Journal:  Thorac Cardiovasc Surg       Date:  1997-02       Impact factor: 1.827

6.  Evidence that combination therapy using cobra venom factor, splenectomy, and deoxyspergualin is effective in guinea pig to rat cardiac xenotransplantation.

Authors:  S Hayashi; M Ito; I Yokoyama; H Takagi
Journal:  Transplantation       Date:  1994-03-15       Impact factor: 4.939

7.  In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression.

Authors:  A S Chong; W Huang; W Liu; J Luo; J Shen; W Xu; L Ma; L Blinder; F Xiao; X Xu; C Clardy; P Foster; J A Williams
Journal:  Transplantation       Date:  1999-07-15       Impact factor: 4.939

8.  Tracheal transplantation for carinal reconstruction in dogs.

Authors:  K Kawahara; K Inutsuka; M Hiratsuka; S Makihata; K Okabayashi; T Shiraishi; T Shirakusa
Journal:  J Thorac Cardiovasc Surg       Date:  1998-09       Impact factor: 5.209

Review 9.  New immunosuppressive regimens in lung transplantation.

Authors:  N Briffa; R E Morris
Journal:  Eur Respir J       Date:  1997-11       Impact factor: 16.671

10.  Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.

Authors:  L A Valdivia; M Monden; M Gotoh; Y Nakano; T Tono; T Mori
Journal:  Transplantation       Date:  1990-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.